Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicentre study.

Autor: Ceravalls J; Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain., Ruiz-Villaverde R; Department of Dermatology, University Hospital San Cecilio, Instituto Biosanitario de Granada, Ibs, Granada, Spain., Armesto S; Department of Dermatology, Marqués de Valdecilla University Hospital, Santander, Spain., Fernández-Armenteros JM; Department of Dermatology, Hospital de Viladecans, Barcelona, Spain.; Department of Dermatology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Riera-Monroig J; Department of Dermatology, Hospital Clínic de Barcelona, Barcelona, Spain., Gracia-Cazaña T; Department of Dermatology, Hospital Miguel Servet, Zaragoza, Spain., Quintana-Codina M; Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain., Iglesias-Sancho M; Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain., Salleras M; Department of Dermatology, Hospital Universitari Sagrat Cor, Grupo Quirónsalud, Barcelona, Spain., Moya AI; Department of Dermatology, Hospital Universitario Severo Ochoa, Madrid, Spain., Melgosa Ramos FJ; Department of Dermatology, Hospital Lluís Alcanyís de Xàtiva, Xàtiva, Spain., Ferran M; Department of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Jazyk: angličtina
Zdroj: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.
DOI: 10.1111/jdv.20346
Databáze: MEDLINE